Correlogic Systems (Ovarian Cancer Diagnostics Business) is Biotechnology in United States that focus on developer business. Founded in 2000. They cover business area such as developer, diagnostic test, ovarian cancer, ovarian tumor study, three biomarker-relate pende U.S. patent, proprietary software.
2000
( 24 years old in 2024 )
Developer
-
1405 Research Boulevard
Suite 220
Rockville, MD 20850
United States
Private
developerdiagnostic testovarian cancerovarian tumor studythree biomarker-relate pende U.S. patentproprietary software
* We use standard office opening hours in near Correlogic Systems (Ovarian Cancer Diagnostics Business)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Correlogic Systems (Ovarian Cancer Diagnostics Business) is Biotechnology business from United States that founded in 2000 (24 years old in 2024), Correlogic Systems (Ovarian Cancer Diagnostics Business) business is focusing on Developer.
Correlogic Systems (Ovarian Cancer Diagnostics Business) headquarter office and corporate office address is located in 1405 Research Boulevard Suite 220 Rockville, MD 20850 United States.
Correlogic Systems (Ovarian Cancer Diagnostics Business) was founded in United States.
In 2024, Correlogic Systems (Ovarian Cancer Diagnostics Business) is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Correlogic Systems (Ovarian Cancer Diagnostics Business), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
